Large Bore Vascular Closure Devices Market Share Driven by Minimally Invasive Procedures and Interventional Cardiology Expansion | Valuates Reports

Large Bore Vascular Closure Devices Market Size
In 2024, the global market size of Large Bore Vascular Closure Devices was estimated to be worth US$ 705 million and is forecast to reach approximately US$ 1215 million by 2031 with a CAGR of 8.2% during the forecast period 2025-2031.

View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-35F2413/Global_Large_Bore_Vascular_Closure_Devices_Market_Insights_Forecast_to_2026

The Large Bore Vascular Closure Devices Market is witnessing steady market growth as hospitals and interventional centers increasingly adopt minimally invasive procedures that require reliable post-procedural hemostasis. Key market trends influencing market size include the growing use of large bore catheters in structural heart interventions, advancements in closure technology to reduce complications, and rising procedural volumes in cardiac and vascular care. Shifts toward faster patient recovery, reduced hospital stay, and improved procedural safety continue to strengthen demand across clinical settings.

By type, active closure devices hold the largest market share due to their ability to provide rapid and secure vessel closure following large bore access procedures. These devices are widely adopted in complex interventions where precision and immediate hemostasis are critical. Passive closure devices maintain a stable presence in the market, particularly in procedures where gradual closure and simplicity of use are preferred, supporting overall market growth across diverse clinical protocols.

From an application perspective, femoral arterial access represents the dominant segment, driven by its extensive use in transcatheter valve replacement, endovascular aneurysm repair, and other high-complexity interventions. The transradial arterial segment is expanding at a notable pace as clinicians increasingly explore alternative access routes to reduce bleeding risk and improve patient comfort, contributing to evolving market trends in access-site management.

Leading companies such as Abbott Vascular, Abbott, Cardinal Health, Vascular Solutions, Essential Medical, InSeal Medical, Medeon Biodesign, Transluminal Technologies, Vasorum, and Morris Innovative play a pivotal role in shaping market share. These companies focus on device reliability, ease of deployment, and compatibility with large bore systems. Ongoing product development, clinical validation, and strategic collaborations with healthcare providers strengthen their competitive positioning and support sustained market growth.

Regionally, North America commands a significant share of the market, supported by advanced healthcare infrastructure, high adoption of interventional procedures, and strong clinical acceptance of innovative closure technologies. Europe follows closely, driven by expanding structural heart programs and standardized procedural practices. Asia-Pacific shows the fastest market growth as access to advanced cardiovascular care improves across major economies. The market forecast remains positive, supported by continued innovation in closure mechanisms, expanding procedural adoption, and growing emphasis on patient safety and procedural efficiency worldwide.

Segment by Type

• Passive Closure Devices
• Active Closure Devices

Segment by Application

• Femoral Arterial
• Transradial Arterial

By Company

Abbott Vascular, Abbott, Vascular Solutions, Essential Medical, InSeal Medical, Medeon Biodesign, Morrris Innovative, Transluminal Technologies, Vasorum, Cardinal Health

View full report
https://reports.valuates.com/market-reports/QYRE-Auto-35F2413/global-large-bore-vascular-closure-devices

Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.